Ischaemic heart disease in Africa

Heart

Volumn 94, Issue 7, 2008, Pages 836-843

  Mensah, G A ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ABDOMINAL OBESITY; ACUTE HEART INFARCTION; AFRICA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CIGARETTE SMOKING; COMBINATION CHEMOTHERAPY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; EPIDEMIC; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH PROMOTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; URBANIZATION;

ADULT; AFRICA; AGED; AGED, 80 AND OVER; DEVELOPING COUNTRIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POPULATION DYNAMICS; RISK FACTORS;

EID: 46249088202     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.136523     Document Type: Review

References (69)

1. World Health Organization. The World Health report 2001: reducing risks, promoting healthy life. Geneva, Switzerland: WHO, 2002.
2. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, et al, eds. Global burden of disease and risk factors. New York, NY, and Washington, DC: Oxford University Press & The World Bank, 2006:45-240.
3. Rao C, Lopez AD, Hemed Y. Causes of death. In: Jamison DT, Feachem RG, Makgoba MW, et al, eds. Disease and mortality in sub-Saharan Africa. 2nd ed. Washington, DC: The World Bank, 2006:67-82.
4. World Health Organization, Department of Measurement and Health Information. Projections of mortality and burden of disease by region, 2006. Available at http://www.who.int/healthinfo/statistics/ bod_deathbyregion.xls (accessed 30 March 2008).
5. Biritwum RB, Amoah AGB, Pobee JOM. Cardiovascular diseases in sub-Saharan Africa. Accra, Ghana: ASCOM Publishers, 2005.
6. Pobee JO. Cardiovascular research: a luxury in tropical Africa? East Afr Med J 1987;64:396-410.
7. Cooke AR. Notes on the disease met with in Uganda, central Africa. J Trop Med 1901;4:175-8.
8. Shaper AG, Shaper LJ. Analysis of medical admissions to Mulago Hospital. East Afr Med J 1958;35:647-78.
9. Becker BJP. Cardio-vascular disease in the Bantu and coloured races of South Africa. IV. Atheromatosis. S Afr Med J 1946;11:97-105.
10. Walker AR, Sareli P. Coronary heart disease: outlook for Africa. J R Soc Med 1997;90:23-7.
11. Pobee JOM. A view of cardiovascular disease in the African continent. Cardiovasc Epidemiol Newslet 1979;26:23.
12. Falase AO, Cole TO, Osuntokun BO. Myocardial infarction in Nigerians. Trop Geogr Med 1973;25:147-50.
13. The World Bank. Africa development indicators 2006. Washington, DC: The World Bank, 2006.
14. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971;49:509-38.
15. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q 1986;64:355-91.
16. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-53.
17. Leeder S, Raymond S, Greenberg H, et al. A race against time: the challenge of cardiovascular disease in developing countries. New York, NY: Trustees of Columbia University, 2004.
18. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005;112:3547-53.
19. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64.
20. Walker RW, McLarty DG, Kitange HM, et al. Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet 2000;355:1684-7.
21. Cooper RS, Amoah AG, Mensah GA. High blood pressure: the foundation for epidemic cardiovascular disease in African populations. Ethn Dis 2003;13(Suppl 2):S48-52.
22. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.
23. Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 2005;112:3554-61.
24. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937- 52.
25. Murray CJL, Lopez AD. The global burden of disease: a comparative assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996.
26. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
27. Akinboboye O, Idris O, Akinboboye O, et al. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens 2003;17:381-7.
28. Alberts M, Urdal P, Steyn K, et al. Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovasc Prev Rehabil 2005;12:347-54.
29. Mollentze WF, Moore AJ, Steyn AF, et al. Coronary heart disease risk factors in a rural and urban Orange Free State black population. S Afr Med J 1995;85:90-6.
30. Ezzati M, Vander Hoorn S, Lopez AD, et al. Comparative quantification of mortality and burden of disease attributable to selected risk factors. In: Lopez AD, Mathers CD, Ezzati M, et al, eds. Global burden of disease and risk factors. New York: Oxford University Press, 2006:241-396.
31. Anim JT. Pattern of atherosclerosis in a Ghanaian adult population: an autopsy study. Afr J Med Med Sci 1987;16:203-12.
32. Maru M. Coronary atherosclerosis and myocardial infarction in autopsied patients in Gondar, Ethiopia. J R Soc Med 1989;82:399- 401.
33. Grinbaum A, Rosenthal T, Peleg E, et al. Ischaemic heart disease risk factors in young black Africans from urban Zaire. J Hum Hypertens 1993;7:555-7.
34. Maru M. The changing pattern of cardiovascular diseases in Ethiopia. East Afr Med J 1993;70:772-6.
35. Betre M, Kebede D, Kassaye M. Modifiable risk factors for coronary heart disease among young people in Addis Ababa. East Afr Med J 1997;74:376-81.
36. Mamo Y, Oli K. Trends of acute myocardial infarction admissions over a decade, Tikur Anbessa Hospital. Ethiop Med J 2001;39:193- 202.
37. Opadijo OG, Akande AA, Jimoh AK. Prevalence of coronary heart disease risk factors in Nigerians with systemic hypertension. Afr J Med Med Sci 2004;33:121-5.
38. Chillemi R, Simpore J, Persichilli S, et al. Elevated levels of plasma homocysteine in postmenopausal women in Burkina Faso. Clin Chem Lab Med 2005;43:765-71.
39. Mpabulungi L, Muula AS. Tobacco use among high school students in a remote district of Arua, Uganda. Rural Remote Health 2006;6:609.
40. Sani MU, Adamu B, Mijinyawa MS, et al. Ischaemic heart disease in Aminu Kano Teaching Hospital, Kano, Nigeria: a 5 year review. Niger J Med 2006;15:128-31.
41. Mensah GA, Dietz WH, Harris VB, et al. Prevention and control of coronary heart disease and strokenomenclature for prevention approaches in public health: a Statement for public health practice from the Centers for Disease Control and Prevention. Am J Prev Med 2005;29(Suppl 1):152-7.
42. US Department of Health and Human Services. A public health action plan to prevent heart disease and stroke. http://www.cdc.gov/dhdsp/ library/action_plan/pdfs/action_plan_full.pdf; Accessed on December 12, 2007.
43. Rose G. The strategy of preventive medicine. New York, NY: Oxford University Press, 1992.
44. Manuel DG, Lim J, Tanuseputro P, et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006;332:659- 62.
45. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984;101:825-36.
46. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994;309:23-7.
47. Bots ML, Grobbee DE. Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors. J Cardiovasc Risk 1996;3:271-6.
48. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
49. van der Sande MA, Coleman RL, Schim van der Loeff MF, et al. A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa. Health Policy Plan 2001;16:345-50.
50. Kadiri S. Tackling cardiovascular disease in Africa. BMJ 2005;331:711-2.
51. Mensah GA. Tackling cardiovascular diseases in Africa: words into action. BMJ 2005;331 (Rapid Response Online; available at http://www.bmj.com/cgi/eletters/331/7519/711#118991 (accessed 29 March 2008)).
52. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Worldwide efforts to improve heart health: a followup to the Catalonia Declaration_selected program descriptions. Available at http://www.internationalhearthealth.org/ Publications/catalonia.pdf; Accessed on December 12, 2007.
53. Bonow RO, Smaha LA, Smith SC Jr, et al. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-5.
54. Wilson EE. The role of the World Heart Federation in cardiovascular health promotion and disease prevention in developing countries with a special emphasis on sub-Saharan Africa. Ethn Dis 2003;13(Suppl 2):S164-6.
55. World Health Organization. The Bangkok Charter for Health Promotion in a Globalized World. Available at http://www.who.int/ healthpromotion/conferences/6gchp/bangkok-charter/en/print.html. Accessed on December 12, 2007.
56. World Health Organization. Preventing chronic diseases : a vital investment. Geneva: World Health Organization, 2005.
57. World Health Organization. WHO framework convention on tobacco control. Geneva: The World Health Organization, 2003.
58. World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: WHO, 2002.
59. World Health Organization. Framework for countrywide plans of action for health promotion. Geneva: World Health Organization, 2000.
60. World Health Organization. The fifth global conference on health promotion. Health promotion: bridging the equity gap. Geneva: World Health Organization, 2000.
61. World Health Organization. Global strategy on diet, physical activity and health. Geneva: World Health Organization, 2004.
62. World Health Organization African Regional Office. Implementation of the framework convention on tobacco control in the African region: current status and the way forward. Available at http://www.afro.who.int/rc55/documents/afr_rc55_13_tobacco_control.pdf (accessed 29 March 2008).
63. World Health Organization. WHO CVD-risk management package for low- and medium-resource settings. Geneva: World Health Organization, 2002.
64. Robberstad B, Hemed Y, Norheim OF. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Eff Resour Alloc 2007;5:3.
65. Gaziano TA, Steyn K, Cohen DJ, et al. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation 2005;112:3569-76.
66. Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood) 2007;26:13-24.
67. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006; 368:679-86.
68. World Health Organization. Some strategies to reduce risk. The world health report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: WHO, 2002:101-44.
69. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.